Astrana Health, Inc. (ASTH)
(Delayed Data from NSDQ)
$21.81 USD
-0.51 (-2.28%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $21.79 -0.02 (-0.09%) 7:58 PM ET
1-Strong Buy of 5 1
A Value D Growth C Momentum B VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ASTH 21.81 -0.51(-2.28%)
Will ASTH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ASTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASTH
Power Up Your Portfolio Value With These 5 High Earnings Yield Stocks
ASTH vs. CHE: Which Stock Is the Better Value Option?
ASTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Think Astrana Health, Inc. (ASTH) Could Surge 97.29%: Read This Before Placing a Bet
Zacks.com featured highlights Astrana Health, KT, Upbound, Noah Holdings and DXP Enterprises
All You Need to Know About Astrana Health, Inc. (ASTH) Rating Upgrade to Strong Buy
Other News for ASTH
Astrana Health (ASTH) Faces Price Target Cut Amid Cost Concerns
Astrana Health price target lowered by $20 at BTIG, here's why
Astrana Health, Inc. Schedules 2025 Second Quarter Financial Results Release and Conference ...
Astrana Health Inc (ASTH) Trading Down 5.35% on Jul 18
Astrana Health Inc (ASTH) Shares Gap Down to $24.7 on Jul 11